Urinary Tract Infection and Progression to Pyelonephritis: Group B Streptococcus versus E. coli

被引:2
作者
Sachdeva, Sarika [1 ]
Rosett, Heather A. [2 ]
Krischak, Madison K. [3 ]
Weaver, Kristin E. [4 ]
Heine, R. Phillips [5 ]
Denoble, Anna E. [6 ]
Dotters-Katz, Sarah K. [4 ]
机构
[1] Johns Hopkins Univ, Dept Pediat, Baltimore, MD USA
[2] Univ Utah, Dept OBGYN, Salt Lake City, UT USA
[3] Univ Michigan, Dept Urol, Ann Arbor, MI USA
[4] Duke Univ, Dept Obstet & Gynecol, 2608 Erwin Rd,Suite 210, Durham, NC 27705 USA
[5] Atrium Hlth Wake Forest, Dept Obstet & Gynecol, Winston Salem, NC USA
[6] Yale Univ, Dept Obstet & Gynecol, New Haven, CT USA
来源
AJP REPORTS | 2024年 / 14卷 / 01期
关键词
acute cystitis; asymptomatic bacteriuria; E; coli; GBS; pregnancy; pyelonephritis; pyelonephritis-related morbidity; urinary tract infection; uropathogens; MORBIDITY;
D O I
10.1055/s-0044-1779031
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective Group B Streptococcus (GBS) colonization of the lower urinary tract in pregnancy is associated with severe infections such as chorioamnionitis, endometritis, and pyelonephritis. The objective of this study was to compare rates of progression to pyelonephritis between GBS and Escherichia coli lower urinary tract infections (LUTIs), as well as compare infectious and obstetric morbidity secondary to these pathogens. Study Design Retrospective cohort of pregnant women with LUTIs (asymptomatic bacteria or acute cystitis [AC]) from a single health system between July 2013 and May 2019. Demographic, infectious, antepartum, and intrapartum data were abstracted from medical records of women with GBS or E. coli LUTI. The primary outcome was progression to pyelonephritis. Secondary outcomes included pyelonephritis-related anemia, sepsis, pyelonephritis length of stay (LOS), median gestational age (GA) at delivery, preterm delivery, and low birth weight (LBW). Logistic regression was used to calculate the adjusted odds of the primary outcome. Results Of 729 pregnant women with urinary colonization, 433 were culture positive for one of the aforementioned bacteria, with 189 (43.6%) having GBS and 244 (56.4%) having E. coli. Women with E. coli were more likely to be younger, use tobacco, have a history of AC, and have a history of preterm birth. Rates of progression to pyelonephritis were markedly higher with E. coli (15.6%) than with GBS (1.1%; p <0.001). Median LOS for pyelonephritis and pyelonephritis-related morbidities did not differ. Median GA at delivery, preterm delivery, and LBW rates also did not differ. In adjusted analysis, controlling for history of AC, insurance status, tobacco use, prior preterm birth, primary infection type, and maternal age, women with GBS LUTI had markedly decreased odds of developing pyelonephritis in pregnancy compared with those with E. coli (adjusted odds ratio: 0.04, 95% confidence interval: 0.01-0.28). Conclusion Escherichia coli infections progress to pyelonephritis in pregnancy at markedly higher rates than GBS, although obstetric outcomes are similar.
引用
收藏
页码:e80 / e84
页数:5
相关论文
共 50 条
  • [31] Evaluation of hematogenous spread and ascending infection in the pathogenesis of acute pyelonephritis due to group B streptococcus in mice
    Sullivan, Matthew J.
    Ulett, Glen C.
    MICROBIAL PATHOGENESIS, 2020, 138
  • [32] Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection
    Elsa Roldan-Masedo
    Talia Sainz
    Almudena Gutierrez-Arroyo
    Rosa Maria Gomez-Gil
    Estefania Ballesteros
    Luis Escosa
    Fernando Baquero-Artigao
    Ana Méndez-Echevarría
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 2097 - 2102
  • [33] A cynomolgus monkey E. coli urinary tract infection model confirms efficacy of new FimH vaccine candidates
    Chorro, Laurent
    Ciolino, Tara
    Torres, Caresse Lynn
    Illenberger, Arthur
    Aglione, Johnpaul
    Corts, Paula
    Lypowy, Jacqueline
    Ponce, Christopher
    La Porte, Annalena
    Burt, Deborah
    Volberg, Gretchen L.
    Ramaiah, Lila
    Mcgovern, Kathryn
    Hu, Jianfang
    Anderson, Annaliesa S.
    de Monerri, Natalie C. Silmon
    Kanevsky, Isis
    Donald, Robert G. K.
    INFECTION AND IMMUNITY, 2024, 92 (10)
  • [34] SURVEY OF ANTIBIOTIC-RESISTANCE PATTERNS IN E. COLI ISOLATED FROM PATIENTS WITH URINARY TRACT INFECTION IN RASHT
    Rahimabadi, Kolsom Asadpour
    Tabar, Gholamreza Hashemi
    Mojtahedi, Ali
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2014, 43 : 112 - 112
  • [35] GENOTYPING OF E. COLI ISOLATES FROM CHILDREN WITH URINARY TRACT INFECTION BY PULSE FIELD GEL ELECTROPHORESIS (PFGE)
    Navidinia, Masoumeh
    Peerayeh, Shahin Najar
    Fallah, Fatemeh
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2014, 43 : 108 - 108
  • [36] Development of Phage Cocktails to Treat E. coli Catheter-Associated Urinary Tract Infection and Associated Biofilms
    Sanchez, Belkys C.
    Heckmann, Emmaline R.
    Green, Sabrina I.
    Clark, Justin R.
    Kaplan, Heidi B.
    Ramig, Robert F.
    Hines-Munson, Casey
    Skelton, Felicia
    Trautner, Barbara W.
    Maresso, Anthony W.
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [37] Risk Factors for Community-Acquired Urinary Tract Infection Due to Quinolone-Resistant E. coli
    R. Colodner
    I. Kometiani
    B. Chazan
    R. Raz
    Infection, 2008, 36 : 41 - 45
  • [38] Phenotypic And Molecular Screening of Extended Spectrum β-Lactamase ESBLS in MDR- E. Coli Isolated from Urinary Tract Infection Cases
    Abed, Ahmed Dhahir
    Mutter, Thamer Yousif
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 1156 - 1160
  • [39] Group B Streptococcus growth in human urine is associated with asymptomatic bacteriuria rather than urinary tract infection and is unaffected by iron sequestration
    Ipe, Deepak S.
    Goh, Kelvin G. K.
    Desai, Devika
    Ben-Zakour, Nouri
    Sullivan, Matthew J.
    Beatson, Scott A.
    Ulett, Glen C.
    MICROBIOLOGY-SGM, 2025, 171 (01):
  • [40] Streptococcus pneumoniae urinary tract infection in pedeatrics
    Pougnet, Richard
    Sapin, Jeanne
    De Parscau, Loic
    Pougnet, Laurence
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (03) : 348 - 350